1st Xarelto MDL Bellwether Trial Ends In Defense Verdict For Bayer, Janssen

(May 4, 2017, 1:24 PM EDT) -- NEW ORLEANS — The first Xarelto multidistrict litigation bellwether trial ended May 3 with a defense verdict for co-defendants Janssen Pharmaceuticals Inc. and Bayer Pharma AG (In Re:  Xarelto Products Liability...
To view the full article, register now.